Literature DB >> 28194059

NK/T Cell Lymphoma: A Tertiary Centre Experience.

Neeraj Arora1, Arpan Mehta1, Sriram Ravichandran2, Indu Arun3, Rimpa Basu Achari4, Anupam Chakrapani2, Saurabh Jayant Bhave2, Mammen Chandy2, Reena Nair2.   

Abstract

Extranodal NK/T-cell lymphoma (ENKTL), nasal type, is a rare type of non-Hodgkin lymphoma that is commonly seen in East Asian countries and is associated with Epstein-Barr virus infection. This is a retrospective study where we describe nine cases of ENKTL; nasal type diagnosed and treated at our center over a period of 2 years. These cases were analyzed retrospectively for clinical presentation (age, sex, site of involvement), immunophenotype, treatment, response and toxicity profile. Sino-nasal symptoms (blocked nose, headache, epistaxis, regurgitation) were the most common presenting complaints (n = 8). Almost 67 % (n = 6/9) of the cases were referred from Bhutan. Necrosis and angiocentricity were the commonest histological features. Depending on the stage of the disease patient were initially treated with chemotherapy (SMILE/CHOP) and Radiotherapy (IFRT). We describe our experience of management of ENKTL, where we observe that Bhutan could be endemic region for this rare tumour.

Entities:  

Keywords:  NK/T cell lymphoma; SMILE in NK/T cell lymphoma; SMILE therapy; T-cell lymphomas in India

Year:  2016        PMID: 28194059      PMCID: PMC5280857          DOI: 10.1007/s12288-016-0675-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  14 in total

1.  SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.

Authors:  Yok-Lam Kwong; Won Seog Kim; Soon Thye Lim; Seok Jin Kim; Tiffany Tang; Eric Tse; Anskar Y H Leung; Chor-Sang Chim
Journal:  Blood       Date:  2012-08-23       Impact factor: 22.113

2.  Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years.

Authors:  W-Y Au; S-Y Ma; C-S Chim; C Choy; F Loong; A K W Lie; C C K Lam; A Y H Leung; E Tse; C-C Yau; R Liang; Y-L Kwong
Journal:  Ann Oncol       Date:  2005-02       Impact factor: 32.976

3.  Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.

Authors:  Ye-Xiong Li; Bo Yao; Jing Jin; Wei-Hu Wang; Yue-Ping Liu; Yong-Wen Song; Shu-Lian Wang; Xin-Fan Liu; Li-Qiang Zhou; Xiao-Hui He; Ning Lu; Zi-Hao Yu
Journal:  J Clin Oncol       Date:  2006-01-01       Impact factor: 44.544

4.  CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

Authors:  W S Kim; S Y Song; Y C Ahn; Y H Ko; C H Baek; D Y Kim; S S Yoon; H G Lee; W K Kang; H J Lee; C H Park; K Park
Journal:  Ann Oncol       Date:  2001-03       Impact factor: 32.976

5.  The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists.

Authors: 
Journal:  Pathol Int       Date:  2000-09       Impact factor: 2.534

6.  Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

Authors:  Motoko Yamaguchi; Yok-Lam Kwong; Won Seog Kim; Yoshinobu Maeda; Chizuko Hashimoto; Cheolwon Suh; Koji Izutsu; Fumihiro Ishida; Yasushi Isobe; Eisaburo Sueoka; Junji Suzumiya; Takao Kodama; Hiroshi Kimura; Rie Hyo; Shigeo Nakamura; Kazuo Oshimi; Ritsuro Suzuki
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

7.  Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index.

Authors:  Chor-Sang Chim; Shing-Yan Ma; Wing-Yan Au; Carolyn Choy; Albert K W Lie; Raymond Liang; Chun-Chung Yau; Yok-Lam Kwong
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

8.  Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection.

Authors:  D A Arber; L M Weiss; P F Albújar; Y Y Chen; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

9.  Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies.

Authors:  Pek-Lan Khong; Clara B Y Pang; Raymond Liang; Yok-Lam Kwong; Wing-Yan Au
Journal:  Ann Hematol       Date:  2008-05-29       Impact factor: 3.673

10.  Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality.

Authors:  Michael M C Cheung; John K C Chan; Wai-hon Lau; Roger K C Ngan; William W L Foo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

View more
  1 in total

Review 1.  Extranodal NK/T Cell Lymphoma, Nasal Type with Palatal Involvement: A Rare Case Report and Literature Review.

Authors:  Anastasia Andreou; Grigorios Thermos; Alexandra Sklavounou-Andrikopoulou
Journal:  Head Neck Pathol       Date:  2020-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.